Inhibition of lipopolysaccharide-induced pro-inflammatory cytokine expression via suppression of nuclear factor-κB activation by Mallotus japonicus phloroglucinol derivatives

Biochimica et Biophysica Acta - General Subjects

Volumn 1620, Issue 1-3, 2003, Pages 108-118

  Ishii, Rie ^a   Horie, Masakazu ^a   Saito, Koichi ^a   Arisawa, Munehisa ^b   Kitanaka, Susumu ^c  

^a SAITAMA INSTITUTE OF PUBLIC HEALTH   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

Interleukin 6; Macrophage; Mallotus japonicus; Nuclear factor B; Phloroglucinol derivative; Tumor necrosis factor

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; ISOMALLOTOCHROMANOL; ISOMALLOTOCHROMENE; LIPOPOLYSACCHARIDE; MALLOTUS JAPONICUS EXTRACT; MESSENGER RNA; PHLOROGLUCINOL DERIVATIVE; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; HUMAN; HUMAN CELL; MACROPHAGE; MALLOTUS JAPONICUS; MEDICINAL PLANT; MOLECULAR BIOLOGY; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PERICARP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MALLOTUS JAPONICUS; MURINAE;

EID: 0037451648     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00514-7     Document Type: Article

References (40)

1. Arisawa M., Fujita A., Saga M., Hayashi T., Marita N. Studies on cytotoxic constituents in pericarps of Mallotus japonicus. Part II. J. Nat. Prod. 49:1986;298-302.
2. Arisawa M., Fujita A., Morita N., Koshimura S. Cytotoxic and antitumor constituents in pericarps of Mallotus japonicus. Planta Med. 56:1990;377-379.
3. 3H-choline incorporation into cellular phospholipids by phloroglucinol derivatives from Mallotus japonicus. J. Nat. Prod. 54:1991;1409-1412.
4. Arisawa M., Fujita A., Hayashi T., Hayashi K., Ochiai H., Morita N. Cytotoxic and antiherpetic activity of phloroglucinol derivatives from Mallotus japonicus (Euphorbiaceae). Chem. Pharm. Bull. 38:1990;1624-1626.
5. Nakane H., Arisawa M., Fujita A., Koshimura S., Ono K. Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives. FEBS Lett. 286:1991;83-85.
6. R. Ishii, M. Horie, K. Saito, M. Arisawa, S. Kitanaka, Inhibitory effects of phloroglucinol derivatives from Mallotus japonicus on nitric oxide production by Murine Macrophage-like cell line, RAW 264.7, activated by lipopolysaccharide and interferon-γ, Biochim. Biophys. Acta, in press.
7. Adams D.O., Hamilton T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:1984;283-318.
8. Brennan F.M., Maini R.N., Feldmann M. Cytokine expression in chronic inflammatory disease. Br. Med. Bull. 51:1995;368-384.
9. Cutolo M., Sulli A., Barone A., Seriolo B., Accardo S. Macrophages, synovial tissue and rheumatoid arthritis. Clin. Exp. Rheumatol. 11:1993;331-339.
10. Liote F., Boval-Boizard B., Weill D., Kuntz D., Wautier J.L. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin. Exp. Immunol. 106:1996;13-19.
11. Beuther B., Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Ann. Rev. Biochem. 57:1988;505-518.
12. Xie Q.-W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705-4708.
13. Jongeneel C.V. Transcriptional regulation of the tumor necrosis factor α gene. Immunobiology. 193:1995;210-216.
14. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., Jongeneel C.V. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171:1990;35-47.
15. Collart M.A., Baeuerle P., Vassalli P. Regulation of tumor necrosis factor α transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1990;1498-1506.
16. Drouet C., Shakhov A.N., Jongeneel C.V. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J. Immunol. 147:1991;1694-1700.
17. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-κB transcription factor. Mol. Cell. Biol. 10:1990;2327-2334.
18. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:1995;9558-9563.
19. Howard M., Muchamuel T., Andrade S., Menon S. Interluekin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205-1208.
20. Ohlsson K., Björk P., Bergenfeldt M., Hageman R., Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 348:1990;550-552.
21. Arisawa M., Fujita A., Suzuki R., Hayashi T., Morita N. Studies on cytotoxic constituents in pericarps of Mallotus japonicus. Part I. J. Nat. Prod. 48:1985;455-459.
22. Arisawa M., Fujita A., Hayashi T., Morita N., Kikuchi T., Tezuka Y. Studies on cytotoxic constituents in pericarps of Mallotus japonicus. Part IV. Chem. Pharm. Bull. 38:1990;698-700.
23. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand. J. Clin. Lab. Invest., Suppl. 97:1968;77-89.
24. Ohno N., Asada N., Adachi Y., Yadomae T. Enhancement of LPS triggered TNF-α (tumor necrosis factor-α) production by (1→3)-β-D-glucans in mice. Biol. Pharm. Bull. 18:1995;126-133.
25. Adachi Y., Okazaki M., Ohno N., Yadomae T. Enhancement of cytokine production by macrophages stimulated with (1→3)-β-D-glucans, glifolan (GRN), isolated from Grifola frondosa. Biol. Pharm. Bull. 17:1994;1554-1560.
26. Kanematsu M., Takagi K., Masuda N., Suketa Y. Lead inhibits nitric oxide production transiently by mRNA level in murine macrophage cell lines. Biol. Pharm. Bull. 19:1996;949-951.
27. Wadsworth T.L., Koop D.R. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem. Pharmacol. 57:1999;941-949.
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
29. Baeuerle P.A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
30. Chen C.-C., Wang J.-K., Lin S.-B. Antisense oligonucleotide targeting protein kinase C-α, -βI, or -δ but not -η inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor κB-dependent mechanism. J. Immunol. 161:1998;6206-6214.
31. Baeuerle P.A., Baltimore D. IκB: a specific inhibitor of the NF-κB transcription factor. Science. 242:1988;540-546.
32. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1995;1485-1488.
33. Henkel T., Machleidt T., Alkalay I., Krönke M., Ben-Neriah Y., Baeuerle P.A. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature. 365:1993;182-185.
34. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., Karin M. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1996;1295-1304.
35. Kontny E., Kurowska M., Szczepańska K., Maśliński W. Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes. J. Leukoc. Biol. 67:2000;249-258.
36. Carter A.B., Monick M.M., Hunninghake G.W. Lipopolysaccharide-induced NF-κB activation and cytokine release in human alveolar macrophages is PKC-independent and TK- and PC-PLC-dependent. Am. J. Respir. Cell Mol. Biol. 18:1998;384-391.
37. Castrillo A., Pennington D.J., Otto F., Parker P.J., Owen M.J., Bosca L. Protein kinase cepsilon is required for macrophage activation and defense against bacterial infection. J. Exp. Med. 194:2001;1231-1242.
38. Díaz-Guerra M.J.M., Bodelón O.G., Velasco M., Whelan R., Parker P.J., Boscá L. Up-regulation of protein kinase C-ε promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells. J. Biol. Chem. 271:1996;32028-32033.
39. Shapira L., Sylvia V.L., Halabi A., Soskolne W.A., Van Dyke T.E., Dean D.D., Boyan B.D., Schwartz Z. Bacterial lipopolysaccharide induces early and late activation of protein kinase C in inflammatory macrophages by selective activation of PKC-ε Biochem. Biophys. Res. Commun. 240:1997;629-634.
40. Larsen E.C., DiGennaro J.A., Saito N., Mehta S., Loegering D.J., Mazurkiewicz J.E., Lennartz M.R. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J. Immunol. 165:2000;2809-2817.